Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study
Authors:
- Emilio AttenaEAEmilio Attena
- Stefano AlbaniSAStefano Albani
- Alberto Enrico MaraoloAMAlberto Enrico Maraolo
- Mariano MollicaMMMariano Mollica
- Annunziata De RosaARAnnunziata De Rosa
- Raffaella PisapiaRPRaffaella Pisapia
- Giuseppe FiorentinoGFGiuseppe Fiorentino
- Roberto ParrellaRPRoberto Parrella
- Sergio SeverinoSSSergio Severino
- Vincenzo RussoVincenzo Russo
- 1 July 2021
- journal article
- letter
- Published by Wolters Kluwer Health in Circulation: Arrhythmia and Electrophysiology
- Vol. 14 (7) , 672-674
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Remdesivir for the Treatment of Covid-19 — Final ReportNew England Journal of Medicine, 2020
- Marked Sinus Bradycardia Associated With Remdesivir in COVID-19JACC: Case Reports, 2020
- Remdesivir: Review of Pharmacology, Pre‐clinical Data, and Emerging Clinical Experience for COVID‐19Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2020